XSNX >>2M BID 0106//MONSTA NEWZZZ TODAY
Cleantech Innovator Dr. John Tuttle Joins XsunX Team
2013-05-15 09:00 ET - News Release
ALISO VIEJO, CA -- (Marketwired) -- 05/15/13
XsunX, Inc. (OTCQB: XSNX), the developer of CIGSolar®, a patent-pending technology for the mass production of CIGS solar cells that offers a capital-efficient, low-cost alternative to the use of silicon solar cells, today announced that the Dr. John R. Tuttle had joined the Company's Advisory Board. "John's extensive entrepreneurial background and comprehensive knowledge of the Cleantech industry is the perfect addition to XsunX at just the right time," stated XsunX CEO, Tom Djokovich.
Over the last several years, the Company has been developing its CIGSolar® technology while navigating the solar industry-wide restructuring. Recently XsunX began its transition from focusing on its CIGSolar baseline system design and build-out to marketing of its CIGSolar® technology. The next logical step was the addition of a seasoned industry innovation and business development veteran to aid in this transition and further development of XsunX's business relationships with customers and investors.
"There's been a paradigm shift occurring at virtually every level of the solar industry including, and most significantly, how business, the capital markets, and project finance assess the value of the solar industry as a whole and, more specifically, the value of any particular technology," added XsunX CEO Tom Djokovich. "Our current requirement was to find someone with world-class CIGS experience and someone who could also 'think outside of the box' -- or in the CIGS business -- outside of the vacuum chamber to commercialize technology. Dr. Tuttle's years of noteworthy experience at NREL elevating the science and capabilities of CIGS, and his experience transitioning innovation into operational results provides XsunX with the hands-on capabilities that we were looking for," concluded Mr. Djokovich.
Dr. Tuttle brings 30 years of experience in the semiconductor & photovoltaic industries to XsunX, and for the last several years has focused on assisting with operational and capital management of early-stage companies in the Cleantech sector. Previously, he was the co-founder, Chief Executive & Chairman of DayStar Technologies, Inc. where he took the company from 3 employees to an operational organization with world-class development and pilot production facilities, achieving an over 900% value creation for its IPO shareholders.
From 1986-1997, Dr. Tuttle held the position of Senior Scientist at NREL where his research guided the fabrication of thin-film CIGS PV devices with multiple world-record efficiencies. He has authored/co-authored over 70 publications, 14 Patent's / Patent applications, and conducted over 100 presentations about technology & business development. Dr. Tuttle holds a Ph.D. in EE from the University of Colorado, an M.S. from the Colorado School of Mines and a B.S in Applied and Engineering Physics from Cornell University. Dr. Tuttle is joining as Senior Scientific and Business Advisor to XsunX.
About XsunX
XsunX, Inc. is working to commercialize a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent-pending processing technology, which we call CIGSolar®, focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. These cells match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com.
Safe Harbor Statement
Matters discussed in this press release contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "may," "will," "should," "believes," "expect," "intend," "anticipate," "plan," "estimate" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject to risks and uncertainties that are described in our most recent annual report on Form 10-K under the heading "Risk Factors" and our subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements whether as a result of the receipt of new information, future events, or otherwise.
XsunX
888-797-4527
www.xsunx.com
XSNX 2M BID 0106//MONSTA NEWZZZ TODAY Cleantech Innovator
Top 10 Most Recent News Articles
Countries Eye New Investment Paths at CIFIT 2026
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Delhi Pushes Innovation Against Dryland Challenges
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
PathoSearch: A New Era in Pathology With Visual Search
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue ReadingTop 5 Most Recently Viewed Articles
Discovering Opportunities: North Dakota's Workforce Initiative
Welcome to New Beginnings in North Dakota As the season of relocation kicks off, North Dakota is inviting jobseekers with its innovative campaign, Find the Good Life in North Dakota. This initiative coincides with National Moving Day, marking the start of a bustling season when many families seek new horizons across the country. Embrace New Opportunities "People are on...
Continue Reading
Caseware Innovations Garner Multiple Industry Accolades
Celebrating Industry Recognition Caseware™, a pioneer in AI-enabled audit, financial reporting, and data analytics, has recently basked in a wave of industry accolades. These recognitions underscore the company's unmatched leadership in driving innovation and delivering impactful solutions to accounting professionals worldwide. A Double Triumph for Caseware In a...
Continue Reading
Telomir Pharmaceuticals' 31% Surge and Pre-market Movers
Telomir Pharmaceuticals Sees Significant Pre-market Surge Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1. Promising Preclinical Study Results The biotechnology firm disclosed these...
Continue Reading
Tech Stocks Likely to Experience Significant Rebound Soon
Market Overview for Potential Rebounds The stock market is often unpredictable, with certain stocks experiencing declines even after positive earnings reports. In recent times, some stocks have evidently fallen out of favor with investors, particularly following disappointing earnings or cautious guidance from companies. Interestingly, stocks with low expectations can...
Continue Reading
Acer Inc. Reports Impressive Q3 Performance with 36.1% Growth
Acer Inc. Demonstrates Strong Quarter Over Quarter Growth Acer Inc. (TWSE: 2353) has recently shared impressive financial results for the third quarter of 2024, showcasing resilience and growth in a competitive market. The company reported consolidated revenues of NT$72.69 billion, reflecting an 8.3% increase compared to the previous quarter and a 7.8% rise year-on-year....
Continue Reading